ProtoKinetix Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3.10
0.30
371.10
371.00
302.90
136
Total Accounts Receivable
0.10
5.50
8.00
-
-
-
Other Current Assets
21.50
-
0.40
70.40
62.10
1.10
Total Current Assets
24.60
5.80
379.50
441.40
365.10
137.10
Intangible Assets
-
-
70.30
100.70
153.00
187.80
Total Assets
24.60
5.80
449.80
542.10
518.10
324.90
ST Debt & Current Portion LT Debt
443.80
163.30
-
-
117.70
Accounts Payable
174.00
-
-
-
-
Other Current Liabilities
25.00
270.90
45.40
45.30
26.90
Total Current Liabilities
642.80
434.10
45.40
45.30
144.60
Total Liabilities
642.80
434.10
45.40
45.30
144.60
Common Equity (Total)
618.20
428.30
404.40
496.80
373.50
Total Shareholders' Equity
618.20
428.30
404.40
496.80
373.50
Total Equity
618.20
428.30
404.40
496.80
373.50
Liabilities & Shareholders' Equity
24.60
5.80
449.80
542.10
518.10

About ProtoKinetix

View Profile
Address
412 Mulberry Street
Marietta Ohio 45750
United States
Employees -
Website http://www.protokinetix.com
Updated 07/08/2019
Protokinetix, Inc. is a research and development stage biotechnology company, which engages in the scientific medical research of anti-aging glycoproteins. The company was founded on December 23, 1999 and is headquartered in St. Marys, WV.